about
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI B...
Read More
1.50
-0.04
(-2.60%)
47,556
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
GRI Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..